An intravaginal ring for real-time evaluation of adherence to therapy

MOSS, J.A., BAUM, M.M., EASLEY, J.T., COX, D.M. and SMITH, Tony (2017). An intravaginal ring for real-time evaluation of adherence to therapy. PLoS ONE, 12 (4), e0174729.

[img]
Preview
PDF
An intravaginal ring for real-time evaluation of adherence to therapy.pdf - Published Version
Creative Commons Attribution.

Download (1MB) | Preview
Open Access URL: https://journals.plos.org/plosone/article?id=10.13... (Published version)
Link to published version:: https://doi.org/10.1371/journal.pone.0174729
Related URLs:

    Abstract

    © 2017 Moss et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Two recent Phase III clinical trials to investigate an intravaginal ring for preventing HIV infection demonstrated that adherence to prescribed device use was a primary driver of efficacy. Surrogate methods for determining adherence in the studies were limited in their inability to monitor temporal patterns of use and allow deconvolution of the effects of adherence and device efficacy on HIV infection rates. To address this issue, we have developed functionality in an intravaginal ring to continuously monitor when the device is being used and maintain a log of adherence that can be accessed by clinicians after it is removed. An electronic module fabricated with common, inexpensive electronic components was encapsulated in a silicone intravaginal ring. The device uses temperature as a surrogate measure of periods of device insertion and removal, and stores a record of the data for subsequent retrieval. The adherence-monitoring intravaginal ring accurately recorded the device status over 33 simulated IN-OUT cycles and more than 1000 measurement cycles in vitro. Following initial in vitro testing in a temperature-controlled chamber, the device was evaluated in vivo in sheep using a predetermined insertion/removal pattern to simulate intravaginal ring use. After insertion into the vaginal cavity of a sheep, the logged data correctly indicated the device status over 29 hours of continuous measurement including three cycles of insertion and removal. The device described here is a promising, low-cost method for real-time adherence assessment in clinical trials involving medicated intravaginal rings or other intravaginal devices.

    Item Type: Article
    Uncontrolled Keywords: Animals; Anti-HIV Agents; Drug Administration Routes; Female; HIV Infections; Humans; Patient Compliance; Pre-Exposure Prophylaxis; Reverse Transcriptase Inhibitors; Sheep; Software; Tenofovir; Vagina; Vagina; Animals; Sheep; Humans; HIV Infections; Reverse Transcriptase Inhibitors; Anti-HIV Agents; Drug Administration Routes; Patient Compliance; Software; Female; Pre-Exposure Prophylaxis; Tenofovir; MD Multidisciplinary; General Science & Technology
    Identification Number: https://doi.org/10.1371/journal.pone.0174729
    Page Range: e0174729
    SWORD Depositor: Symplectic Elements
    Depositing User: Symplectic Elements
    Date Deposited: 11 Mar 2019 14:59
    Last Modified: 28 Mar 2020 15:21
    URI: http://shura.shu.ac.uk/id/eprint/23363

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics